Therefore, more exploration on the relationship between IR in the second trimester (24–28 weeks) and adverse pregnancy outcomes in GDM women may help identify women who are at high risk of these adverse outcomes, and management can therefore be carried out in early pregnancy even pre-pregnancy, sometimes adding insulin sensitization therapy if necessary to improve the prognosis. Here, INS is linked to gestational diabetes.